Cloning, Expression, and Immunogenicity Analysis of the CpsE Protein from Group B Streptococcus Isolated from Tilapia (Oreochromis Niloticus)

Xi Fu, Kaiyu Wang, Jinlu Huang, Jun Wang, Hai Lian, Yang He, Lanmin Li, Kaiyu Wang

Fish Disease Research Center, College of Veterinary Medicine of Sichuan Agricultural University, Ya’an,China.
Key Laboratory of Animal Disease and Human Health of Sichuan Province, College of Veterinary Medicine of Sichuan Agricultural University, Ya’an, China.

DOI: 10.4236/eng.2012.410B044                

Abstract

Group B Streptococcus (GBS) is a major cause of serious bacterial infection in numerous animal species. The production of capsular polysaccharide(CPs) is vital to GBS to evade host immunity. One of the genes that required for production of CPs, cpsE, has been determined to be well conserved in capsule gene cluster (cps).This study cloned the cpsE gene from Tilapia of GBS clinical isolate (serotype Ia) and expressed this gene with aid of pET-32a(+) in Escherichia coli BL21(DE3) competent cells to obtain high levels of the recombinant protein for further study about CpsE in fish and examination of its immunogenicity. The optimization of induction conditions (IPTG concentration, temperature and time) in E.coli was accomplished and let us to perform the recombinant protein induction at 37℃ for 3h,with 0.2mM IPTG in Luria Bertani (LB) medium. At the optimal conditions, recombinant protein was expressed in an insoluble form (inclusion bodies) and accounted for approximately 23% of the total protein. Purification by affinity chromatography yielded about 480mg fusion protein per liter culture.

Keywords

Recombinant CpsE Expression; Purification; Polyclonal Antibody

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	S.J.Schrag, D.Phil, E.R.Zell, M.Stat, R.Lynfield, A.Roome, K.E.Arnold, A.S.Craig, L.H.Harrison, A.Reingold, K.Stefonek, G.Smith, M.Gamble, A.Schuchat, “A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates,” N. Engl. J. Med. New York, vol.347, pp.233-239, July 2002.
[2]	M.S.Edwards, C.J.Baker, “Group B streptococcal infections in elderly adults,” Clin. Infect. Dis. New York, vol.41 pp.839-847, May 2005.
[3]	T.H.Skoff, M.M.Farley, S.Petit, A.S.Craig, W.Schaffner, K.Gershman, L.H.Harrison, R.Lynfield, J.M.Boetani, S.Zansky, B.A.Albanese, K.Stefonek, E.R.Zell, D.Jackson, T.Thompson, S.J.Schrag, “Increasing burden of invasive group B streptococcal disease in nonpregnant adults 1990-2007,”Clin. Infect. Dis. New York,vol.49 pp.85-92, February 2009.
[4]	G.P.Keefe, “Streptococcus agalactiae mastitis: a review,” Can.Vet.J. Canada,vol.38, pp.429-437,July 1997.
[5]	J.J.Evans, P.H.Klesius, P.M.Gilbert, C.A.Shoemaker, M.A.A.Sarawi, J.Landsberg, R.Duremdez, “Characterization of β-haemolytic group B streptococcus agalactiae in cultured seabream, Sparus auratus L., and wild mullet, Liza klunzingeri (Day), in Kuwait,” J.Fish. Dis.Wiley, New York, vol.25, pp.505-513, September 2002.
[6]	R.Salvador, E.E.Muller, J.C.Freitas, J.H.Leonhadt, “Isolation and characterization of Streptococcus spp. group B in Nile tilapia (Oreochromis niloticus) reared in hapas nets and earth nurseries in the northern region of Parana State,Brazil,” Ciência Rural Santa Maria, vol.35,pp.1374-1378, November 2005.
[7]	A.Eldar, Y.Bejerano, H.Bercovier, “Streptococcus shiloi and Streptococcus difficile: two new streptococcal species causing a meningoencephalitis in fish,” Curr.Microbiol.New York, vol.28, pp.139-143, March 1994.
[8]	E.R.Moxon, J.S.Kroll, “The role of bacterial polysaccharide capsules as virulence factors,” Curr.Top.Microbiol. Immunol.Berlin, vol.150, pp.65-85, May 1990.
[9]	A.S.Cross,“The biologic significance of bacterial encapsulation, ” Curr.Top. Microbiol. Immunol. Berlin, vol.150, pp.87-95, May 1990.
[10]	D.O.Chaffin, S.B.Beres, H.H.Yim, C.E.Rubens, “The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon,” J.Bacteriol.Washington DC, vol.182, pp.4466-4477, May 2000.
[11]	E.Persson, S.Berg, B.Trollfors, P.Larsson, E.Ek, E.Backhaus, B.E.B.Claesson, L.Jonsson, G.Radberg, T.Ripa, S.Johansson, “Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998–2001,” Clin.Microbiol.Infect.Wiley, New York, vol.10, pp.791-796, September 2004.
[12]	H.C.Slotved, F.Kong, L.Lambertsen, S.Sauer, G.L.Gilbert, “Serotype IX, a proposed new Streptococcus agalactiae serotype,” J. Clin. Microbiol. Washington DC, vol.45, pp.2929-2936, September 2007.
[13]	M.E.Hickman, M.A.Rench, P.Ferrieri, C.J.Baker, “Changing epidemiology of group B streptococcal colonization,” Pediatrics. American Academy of Pediatrics, New York, vol.104, pp.203-209, August 1999.
[14]	M.Waqner, T.Murai, B.Waqner, E.Gunther, J.Jelinkova, “JM9 strains, a new type of group B streptococci from Japan,” Zentralbl.Bakteriol. Elsevier, Amsterdam, vol.280, pp.488-496, March 1994.
[15]	N.Suanyuk, F.Kong, D.Ko, G.L.Gilbert, K.Supamattaya, “Occurrence of rare genotypes of Streptococcus agalactiae in cultured red tilapia Oreochromis sp. and Nile tilapia O. niloticus in Thailand—Relationship to human isolates?, ”Aquaculture, Elsevier, Amsterdam, vol.284, pp.35-40, July 2008.
[16]	P.Vandamme, L.A.Devriese, B.Pot, K.Kersters, P.Melin, “Streptococcus difficile is a nonhemolytic group B, type Ib Streptococcus,” IJSEM. Society for General Microbiology, London, vol.47, pp.81-85, January 1997.
[17]	F.Stingele, J.R.Neeser, B.Mollet, “Identification and characterization of the eps (Exopolysaccharide) gene cluster from Streptococcus thermophilus Sfi6,” J.Bacteriol. Washington DC, vol.178, pp.1680-1690, March 1996.
[18]	S.Yamamoto, K.Miyake, Y.Koike, M.Watanabe, Y.Machida, M.Ohta, S.Iijima, “Molecular characterization of type-specific capsular polysaccharide biosynthesis genes of Streptococcus agalactiae type Ia, ”J.Bacteriol. Washington DC, vol.181, pp.5176-5184, September 1999.
[19]	A.Guidolin, J.K.Morona, R.Morona, D.Hansman, J.C.Paton, “Nucleotide sequence analysis of genes essential for capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 19F,” Infect. Immun. Washington DC, vol.62, pp.5384-5396, December 1994.
[20]	M.J.Cieslewicz, D.L.Kasper, Y.Wang, M.R.Wessels, “Functional analysis in type Ia group B Streptococcus of a cluster of genes involved in extracellular polysaccharide production by diverse species of streptococci,” J. Biol. Chem. Washington DC, vol.276, pp.139-146, January 2001.
[21]	J.K.Morona, J.C.Paton, D.C.Miller, R.Morona, “Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniae,” Mol. Microbiol.Wiley, New York, vol.35, pp.1431-1442, March 2000.
[22]	C.E.Rubens, L.M.Heggen, R.F.Haft, M.R.Wessels, “Identification of cpsD,a gene essential for type III capsule expression in group B streptococci,” Mol. Microbiol. Wiley, New York, vol.8, pp.843-855, May 1993.
[23]	A. M. Baya, B. Lupiani, F. M. Hetrick, B. S. Roberson, R. Lukacovic, E. May, C. Poukish, “Association of Streptococcus sp. with fish mortalities in the Chesapeake Bay and its tributaries,” J.Fish.Dis.Wiley,New York, vol.13, pp.251-253, May 1990.
[24]	R.Duremdez, A. A.Marzouk, J. A. Qasem, A. A.Harbi, H. Gharabally, “Isolation of Streptococcus agalactiae from cultured silver pomfret, Pampus argenteus (Euphrasen), in Kuwait,” J.Fish.Dis.Wiley,New York, vol.27, pp.307-310, May 2004.
[25]	N.Suanyuk, H.Kanghear, R. Khongpradit, K.Supamattaya, “Streptococcus agalactiae infection in tilapia (Oreochromis niloticus),” J. Sci. Technol. Aquat .Sci. Songkhla, vol.27, pp.307-319, 2005.
[26]	M. Imperi, M. Pataracchia, G. Alfarone, L. Baldassarri, G. Orefici, R. Creti, “A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae,” J. Microbiol. Methods, Elsevier, Amsterdam, vol.80, pp.212-214, December 2009.
[27]	D. O. Chaffin, L. M. Mentele, C.E. Rubens, “Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression,” J.Bacteriol. Washington DC, vol.187, pp.4615-4626, July 2005.
[28]	A. L. Larentis, A. P. C. Argondizzo, G. dos S. Esteves, El. Jessouron, R. Galler, M. A.Medeiros, “Cloning and optimization of induction conditions for mature PsaA (pneumococcal surface adhesin A) expression in Escherichia coli and recombinant protein stability during long-term storage,” Protein Expr.Purif. Elsevier, Amsterdam, vol.78, pp.38-47, July 2011.